Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
Close up of injection

The year is 1934, and in a laboratory hidden in the basement of the Oxford University Museum of Natural History, a young woman peers at the clear crystals handed to her by the Waynflete Professor of Chemistry at Oxford University. The crystals are made of the peptide hormone insulin, which has been familiar to endocrinologists since 1921. But its intricate structure is still a mystery. 

Its importance, however, was known even before insulin was actually discovered – the name ‘insulin’ was first used by the British physiologist Sir Edward Sharpey-Schafer in 1916, for a hypothetical molecule produced by the pancreatic islets that controls glucose metabolism.

Insulin stopped being hypothetical in 1921, when the Canadian physiologists Frederick Banting and Charles Herbert Best, working in the laboratory of J.J.R. Macleod, isolated insulin from a dog’s pancreas.

On a cold January just a few months later, Leonard Thompson, a 14 year old boy with diabetes, became the first person ever to receive an injection of insulin. Despite a serious allergic reaction, the insulin treatment worked, with usually high levels of blood and urine sugars seen in diabetes dropping to normal – Leonard lived for another 13 years.

“Before the discovery of insulin, there really wasn’t much you could do for people who had diabetes’, said Katharine Owen, Associate Professor of Diabetes and diabetes consultant physician. “It really was a terrible diagnosis.”

100 years after the discovery of insulin made diabetes a treatable illness, it continues to be an active subject of study for scientists, including at Oxford. Endocrine research at the University has long roots, and it was here, in 1934, that the Nobel prize-winning physiologist Dorothy Hodgkin took the first X-ray crystallography photos of an insulin crystal, in her basement laboratory at the Museum of Natural History.

Read the full Oxford Science Blog

Similar stories

Five ways the pandemic has affected routine medical care

Since the beginning of the pandemic, COVID has infected at least a third of the UK population and is estimated to have factored in the deaths of almost 200,000 people in the UK. But critically, COVID has also had a devastating impact on our healthcare systems. While this was expected, new evidence is beginning to reveal the scope of the issue – in particular the effects for people living with long-term health conditions.

Clinical trials for a malaria vaccine start in Mali and Indonesia

Sanaria Inc. announced that two new Phase 2 trials of its pioneering malaria vaccines have started. The first is in 6- to 10-year-old children living in Bancoumana, Mali, a malarious region of West Africa. The second is in Indonesian soldiers based in Sumatra, Indonesia. The soldiers will be deploying for six to nine months this coming August to an intensely malarious district in eastern Indonesia.

Mechanism of expanding bacteria revealed

A new study published in Nature has identified a potential Achilles heel in the protective layers surrounding Gram-negative bacteria that could aid in the development of next-generation antibiotics.

Oxford to receive £7 million to turn bright ideas into global opportunities

The University of Oxford has been awarded more than £7 million, the highest amount of funding given to organisations across the UK, in the latest round of UK Research and Innovation’s (UKRI) Impact Acceleration Account (IAA) funding - aimed at fueling the best, brightest and most disruptive ideas from Uk research institutions.

Discovery of gene involved in chronic pain creates new treatment target

Oxford researchers have discovered a gene that regulates pain sensitisation by amplifying pain signals within the spinal cord, helping them to understand an important mechanism underlying chronic pain in humans and providing a new treatment target.

Oxford's largest ever study into Varicose veins shows need for surgery is linked to genetics

A new international study by Oxford researchers published in Nature Communications establishes for the first time, a critical genetic risk score to predict the likelihood of patients suffering with Varicose veins to require surgery, as well as pointing the way towards potential new therapies.